Discusses the initial spate of initial public offerings (IPOs) by the United States biotech industry in October 2003. List of United States Biotechnology companies that have gone public since October 8, 2003; Lukewarm response of investors to fluctuations in share prices; Cautious optimism on long term outcome of current IPO window.